{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T11:32:54Z","timestamp":1790940774833,"version":"4.1.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,8]],"date-time":"2025-05-08T00:00:00Z","timestamp":1746662400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,5,8]],"date-time":"2025-05-08T00:00:00Z","timestamp":1746662400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100006254","name":"Ruhr-Universit\u00e4t Bochum","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100006254","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Fluids Barriers CNS"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The choroid plexus (ChP) plays a pivotal role in inflammatory processes that occur in multiple sclerosis (MS). The enlargement of the ChP in relapsing-remitting multiple sclerosis (RRMS) is considered to be an indication of disease activity and has been associated with periventricular remyelination failure. This cross-sectional study aimed to identify the relationship between ChP and periventricular tissue damage which occurs in MS, and to elucidate the role of neuroinflammation in primary progressive multiple sclerosis (PPMS).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>ChP volume was assessed by a novel deep learning segmentation method based on structural MRI data acquired from two centers. In total, 141 RRMS and 64 PPMS patients were included, along with 75 healthy control subjects. In addition, T1w\/FLAIR ratios were calculated within periventricular bands to quantify microstructural tissue damage and to assess its relationship to ChP volume.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>When compared to healthy controls, ChP volumes were significantly increased in RRMS, but not in patients with PPMS. T1w\/FLAIR ratios in the normal appearing white matter (NAWM) showing periventricular gradients were decreased in patients with multiple sclerosis when compared to healthy control subjects and lower T1w\/FLAIR ratios radiating out from the lateral ventricles were found in patients with PPMS. A relationship between ChP volume and T1w\/FLAIR ratio in NAWM was found within the inner periventricular bands in RRMS patients. A longer duration of disease was associated with larger ChP volumes only in RRMS patients. Enlarged ChP volumes were also significantly associated with reduced cortex volumes and increased lesion volumes in RRMS.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Our analysis confirmed that the ChP was significantly enlarged in patients with RRMS, which was related to brain lesion volumes and which suggested a dynamic development as it was associated with disease duration. Plexus enlargement was further associated with periventricular demyelination or tissue damage assessed by T1w\/FLAIR ratios in RRMS. Furthermore, we did not find an enlargement of the ChP in patients with PPMS, possibly indicating the reduced involvement of inflammatory processes in the progressive phase of MS. The association between enlarged ChP volumes and cortical atrophy in RRMS highlighted the vulnerability of structures close to the CSF.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12987-025-00656-7","type":"journal-article","created":{"date-parts":[[2025,5,8]],"date-time":"2025-05-08T04:30:11Z","timestamp":1746678611000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Relevance of choroid plexus volumes in multiple sclerosis"],"prefix":"10.1186","volume":"22","author":[{"given":"Britta","family":"Krieger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Bellenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Katharina","family":"Roenneke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theodoros","family":"Ladopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zainab","family":"Abbas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebekka","family":"Rust","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanja","family":"Schmitz-H\u00fcbsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Chien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralf","family":"Gold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Friedemann","family":"Paul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carsten","family":"Lukas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,8]]},"reference":[{"key":"656_CR1","first-page":"766","volume":"353","author":"J Kipnis","year":"2016","unstructured":"Kipnis J. Multifaceted interactions between adaptive immunity and the central nervous system. Sci (1979). 2016;353:766\u201371.","journal-title":"Sci (1979)"},{"key":"656_CR2","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1002\/1097-0029(20010101)52:1<112::AID-JEMT13>3.0.CO;2-5","volume":"52","author":"B Engelhardt","year":"2001","unstructured":"Engelhardt B, Wolburg-Buchholz K, Wolburg H. Involvement of the choroid plexus in central nervous system inflammation. Microsc Res Tech. 2001;52:112\u201329.","journal-title":"Microsc Res Tech"},{"key":"656_CR3","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.jneuroim.2008.04.035","volume":"199","author":"M Vercellino","year":"2008","unstructured":"Vercellino M, Votta B, Condello C, Piacentino C, Romagnolo A, Merola A, et al. Involvement of the choroid plexus in multiple sclerosis autoimmune inflammation: a neuropathological study. J Neuroimmunol. 2008;199:133\u201341.","journal-title":"J Neuroimmunol"},{"key":"656_CR4","doi-asserted-by":"publisher","first-page":"a028936","DOI":"10.1101\/cshperspect.a028936","volume":"8","author":"H Lassmann","year":"2018","unstructured":"Lassmann H. Multiple sclerosis pathology. Cold Spring Harb Perspect Med. 2018;8:a028936.","journal-title":"Cold Spring Harb Perspect Med"},{"key":"656_CR5","doi-asserted-by":"publisher","unstructured":"Manouchehri N, St\u00fcve O. Choroid plexus volumetrics and brain inflammation in multiple sclerosis. Proceedings of the National Academy of Sciences. 2021;118. Available from: https:\/\/doi.org\/10.1073\/pnas.2115221118","DOI":"10.1073\/pnas.2115221118"},{"key":"656_CR6","doi-asserted-by":"publisher","unstructured":"Fleischer V, Gonzalez-Escamilla G, Ciolac D, Albrecht P, K\u00fcry P, Gruchot J et al. Translational value of choroid plexus imaging for tracking neuroinflammation in mice and humans. Proceedings of the National Academy of Sciences. 2021;118. Available from: https:\/\/doi.org\/10.1073\/pnas.2025000118","DOI":"10.1073\/pnas.2025000118"},{"key":"656_CR7","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1148\/radiol.2021204426","volume":"301","author":"VAG Ricigliano","year":"2021","unstructured":"Ricigliano VAG, Morena E, Colombi A, Tonietto M, Hamzaoui M, Poirion E, et al. Choroid plexus enlargement in inflammatory multiple sclerosis: 3.0-T MRI and translocator protein PET evaluation. Radiology. 2021;301:166\u201377.","journal-title":"Radiology"},{"key":"656_CR8","doi-asserted-by":"publisher","first-page":"e1147","DOI":"10.1212\/NXI.0000000000001147","volume":"9","author":"J M\u00fcller","year":"2022","unstructured":"M\u00fcller J, Sinnecker T, Wendebourg MJ, Schl\u00e4ger R, Kuhle J, Sch\u00e4delin S, et al. Choroid plexus volume in multiple sclerosis vs neuromyelitis optica spectrum disorder. Neurol - Neuroimmunol Neuroinflammation. 2022;9:e1147.","journal-title":"Neurol - Neuroimmunol Neuroinflammation"},{"key":"656_CR9","doi-asserted-by":"crossref","unstructured":"Cappelle S, Pareto D, Sunaert S, Smets I, Laenen A, Dubois B et al. T1w\/FLAIR ratio standardization as a myelin marker in MS patients. Neuroimage Clin. 2022;36.","DOI":"10.1016\/j.nicl.2022.103248"},{"key":"656_CR10","doi-asserted-by":"crossref","unstructured":"Thompson AJ, Banwell BL, Barkhof F, Carroll WM, Coetzee T, Comi G et al. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol. 2018;17.","DOI":"10.1016\/S1474-4422(17)30470-2"},{"key":"656_CR11","doi-asserted-by":"publisher","first-page":"e964","DOI":"10.1212\/NXI.0000000000000964","volume":"8","author":"R Rust","year":"2021","unstructured":"Rust R, Chien C, Scheel M, Brandt AU, D\u00f6rr J, Wuerfel J, et al. Epigallocatechin gallate in progressive MS. Neurol - Neuroimmunol Neuroinflammation. 2021;8:e964.","journal-title":"Neurol - Neuroimmunol Neuroinflammation"},{"key":"656_CR12","doi-asserted-by":"publisher","unstructured":"Puonti O, Iglesias JE, Van Leemput K. Fast and sequence-adaptive whole-brain segmentation using parametric Bayesian modeling. Neuroimage. 2016;143:235\u201349. Available from: https:\/\/doi.org\/10.1016\/j.neuroimage.2016.09.011","DOI":"10.1016\/j.neuroimage.2016.09.011"},{"key":"656_CR13","doi-asserted-by":"publisher","unstructured":"Cerri S, Puonti O, Meier DS, Wuerfel J, M\u00fchlau M, Siebner HR et al. A contrast-adaptive method for simultaneous whole-brain and lesion segmentation in multiple sclerosis. Neuroimage. 2021;225:117471. Available from: https:\/\/doi.org\/10.1016\/j.neuroimage.2020.117471","DOI":"10.1016\/j.neuroimage.2020.117471"},{"key":"656_CR14","doi-asserted-by":"crossref","unstructured":"Fischl B. FreeSurfer. Neuroimage. 2012;62:774\u201381.","DOI":"10.1016\/j.neuroimage.2012.01.021"},{"key":"656_CR15","doi-asserted-by":"crossref","unstructured":"Jenkinson M, Beckmann CF, Behrens TE, Woolrich MW, Smith SM. FSL. Neuroimage. 2011\/10\/08. 2012;62:782\u201390.","DOI":"10.1016\/j.neuroimage.2011.09.015"},{"key":"656_CR16","doi-asserted-by":"crossref","unstructured":"Eisma JJ, McKnight CD, Hett K, Elenberger J, Han CJ, Song AK et al. Deep learning segmentation of the choroid plexus from structural magnetic resonance imaging (MRI): validation and normative ranges across the adult lifespan. Fluids Barriers CNS. 2024;21.","DOI":"10.1186\/s12987-024-00525-9"},{"key":"656_CR17","unstructured":"R Core Team. R: a language and environment for statistical computing. Vienna, Austria. 2022. Available from: https:\/\/www.r-project.org\/"},{"key":"656_CR18","doi-asserted-by":"crossref","unstructured":"Lassmann H. Pathogenic mechanisms associated with different clinical courses of multiple sclerosis. Front Immunol. 2019;9.","DOI":"10.3389\/fimmu.2018.03116"},{"key":"656_CR19","doi-asserted-by":"crossref","unstructured":"Lassmann H, Van Horssen J, Mahad D. Progressive multiple sclerosis: pathology and pathogenesis. Nat rev neurol. Nature Publishing Group; 2012. pp. 647\u201356.","DOI":"10.1038\/nrneurol.2012.168"},{"key":"656_CR20","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1093\/brain\/awp070","volume":"132","author":"JM Frischer","year":"2009","unstructured":"Frischer JM, Bramow S, Dal-Bianco A, Lucchinetti CF, Rauschka H, Schmidbauer M, et al. The relation between inflammation and neurodegeneration in multiple sclerosis brains. Brain. 2009;132:1175\u201389.","journal-title":"Brain"},{"key":"656_CR21","doi-asserted-by":"crossref","unstructured":"Angelini G, Bani A, Constantin G, Rossi B. The interplay between T helper cells and brain barriers in the pathogenesis of multiple sclerosis. Front Cell Neurosci. Frontiers Media S.A.; 2023.","DOI":"10.3389\/fncel.2023.1101379"},{"key":"656_CR22","doi-asserted-by":"crossref","unstructured":"Ayub M, Jin HK, Bae J. sung. The blood cerebrospinal fluid barrier orchestrates immunosurveillance, immunoprotection, and immunopathology in the central nervous system. BMB Rep. 2021;54:196\u2013202.","DOI":"10.5483\/BMBRep.2021.54.4.205"},{"key":"656_CR23","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1007\/s00401-013-1227-1","volume":"128","author":"G Kooij","year":"2014","unstructured":"Kooij G, Kopplin K, Blasig R, Stuiver M, Koning N, Goverse G, et al. Disturbed function of the blood-cerebrospinal fluid barrier aggravates neuro-inflammation. Acta Neuropathol. 2014;128:267\u201377.","journal-title":"Acta Neuropathol"},{"key":"656_CR24","doi-asserted-by":"crossref","unstructured":"Alisch JSR, Kiely M, Triebswetter C, Alsameen MH, Gong Z, Khattar N et al. Characterization of age-related differences in the human choroid plexus volume, microstructural integrity, and blood perfusion using multiparameter magnetic resonance imaging. Front Aging Neurosci. 2021;13.","DOI":"10.3389\/fnagi.2021.734992"},{"key":"656_CR25","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/s12987-024-00603-y","volume":"21","author":"Z Sun","year":"2024","unstructured":"Sun Z, Li C, Zhang J, Wisniewski T, Ge Y. Choroid plexus aging: structural and vascular insights from the HCP-aging dataset. Fluids Barriers CNS. 2024;21:98.","journal-title":"Fluids Barriers CNS"},{"key":"656_CR26","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1177\/0271678X221129101","volume":"43","author":"JJ Eisma","year":"2023","unstructured":"Eisma JJ, McKnight CD, Hett K, Elenberger J, Song AK, Stark AJ, et al. Choroid plexus perfusion and bulk cerebrospinal fluid flow across the adult lifespan. J Cereb Blood Flow Metab. 2023;43:269\u201380.","journal-title":"J Cereb Blood Flow Metab"},{"key":"656_CR27","doi-asserted-by":"crossref","unstructured":"Wang X, Zhu Q, Yan Z, Shi Z, Xu Y, Liu Y et al. Enlarged choroid plexus related to iron rim lesions and deep gray matter atrophy in relapsing-remitting multiple sclerosis. Mult Scler Relat Disord. 2023;75.","DOI":"10.1016\/j.msard.2023.104740"},{"key":"656_CR28","doi-asserted-by":"crossref","unstructured":"M\u00fcller J, Sinnecker T, Wendebourg MJ, Schl\u00e4ger R, Kuhle J, Sch\u00e4delin S, et al. Choroid plexus volume in multiple sclerosis vs neuromyelitis optica spectrum disorder: a retrospective, cross-sectional analysis. Neurology(R), neuroimmunology & neuroinflammation. 2022;9.","DOI":"10.1212\/NXI.0000000000001147"},{"key":"656_CR29","doi-asserted-by":"crossref","unstructured":"Ricigliano VAG, Louapre C, Poirion E, Colombi A, Yazdan Panah A, Lazzarotto A et al. Imaging characteristics of choroid plexuses in presymptomatic multiple sclerosis. Neurol Neuroimmunol Neuroinflamm. 2022;9.","DOI":"10.1212\/NXI.0000000000200026"},{"key":"656_CR30","doi-asserted-by":"crossref","unstructured":"Klistorner S, Barnett MH, Parratt J, Yiannikas C, Graham SL, Klistorner A. Choroid plexus volume in multiple sclerosis predicts expansion of chronic lesions and brain atrophy. Ann Clin Transl Neurol. 2022; Available from: https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/acn3.51644","DOI":"10.2139\/ssrn.4091252"},{"key":"656_CR31","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.1093\/brain\/awab025","volume":"144","author":"M Pardini","year":"2021","unstructured":"Pardini M, Brown JWL, Magliozzi R, Reynolds R, Chard DT. Surface-in pathology in multiple sclerosis: a new view on pathogenesis? Brain. 2021;144:1646\u201354.","journal-title":"Brain"},{"key":"656_CR32","doi-asserted-by":"publisher","first-page":"2925","DOI":"10.1093\/brain\/aws189","volume":"135","author":"SR Choi","year":"2012","unstructured":"Choi SR, Howell OW, Carassiti D, Magliozzi R, Gveric D, Muraro PA, et al. Meningeal inflammation plays a role in the pathology of primary progressive multiple sclerosis. Brain. 2012;135:2925\u201337.","journal-title":"Brain"},{"key":"656_CR33","doi-asserted-by":"publisher","first-page":"e1865","DOI":"10.1212\/WNL.0000000000011700","volume":"96","author":"E Poirion","year":"2021","unstructured":"Poirion E, Tonietto M, Lejeune F-X, Ricigliano VAG, Boudot de la Motte M, Benoit C, et al. Structural and clinical correlates of a periventricular gradient of neuroinflammation in multiple sclerosis. Neurology. 2021;96:e1865\u201375.","journal-title":"Neurology"},{"key":"656_CR34","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1093\/brain\/awac334","volume":"146","author":"M Tonietto","year":"2023","unstructured":"Tonietto M, Poirion E, Lazzarotto A, Ricigliano V, Papeix C, Bottlaender M, et al. Periventricular remyelination failure in multiple sclerosis: a substrate for neurodegeneration. Brain. 2023;146:182\u201394.","journal-title":"Brain"},{"key":"656_CR35","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.nicl.2017.07.001","volume":"16","author":"M Pardini","year":"2017","unstructured":"Pardini M, Petracca M, Harel A, Fleysher L, Oesingmann N, Bommarito G, et al. The relationship between cortical lesions and periventricular NAWM abnormalities suggests a shared mechanism of injury in primary-progressive MS. Neuroimage Clin. 2017;16:111\u20135.","journal-title":"Neuroimage Clin"},{"key":"656_CR36","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/1471-2377-12-11","volume":"12","author":"BFG Popescu","year":"2012","unstructured":"Popescu BFG, Lucchinetti CF. Meningeal and cortical grey matter pathology in multiple sclerosis. BMC Neurol. 2012;12:11.","journal-title":"BMC Neurol"},{"key":"656_CR37","doi-asserted-by":"publisher","first-page":"11597","DOI":"10.1523\/JNEUROSCI.2180-11.2011","volume":"31","author":"MF Glasser","year":"2011","unstructured":"Glasser MF, van Essen DC. Mapping human cortical areas in vivo based on myelin content as revealed by T1- and T2-weighted MRI. J Neurosci. 2011;31:11597\u2013616.","journal-title":"J Neurosci"},{"key":"656_CR38","doi-asserted-by":"crossref","unstructured":"Cooper G, Hirsch S, Scheel M, Brandt AU, Paul F, Finke C et al. Quantitative multi-parameter mapping optimized for the clinical routine. Front Neurosci. 2020;14.","DOI":"10.3389\/fnins.2020.611194"},{"key":"656_CR39","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/S1474-4422(21)00095-8","volume":"20","author":"MP Wattjes","year":"2021","unstructured":"Wattjes MP, Ciccarelli O, Reich DS, Banwell B, de Stefano N, Enzinger C, et al. 2021 MAGNIMS\u2013CMSC\u2013NAIMS consensus recommendations on the use of MRI in patients with multiple sclerosis. Lancet Neurol. 2021;20:653\u201370.","journal-title":"Lancet Neurol"},{"key":"656_CR40","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1093\/brain\/awv065","volume":"138","author":"Z Liu","year":"2015","unstructured":"Liu Z, Pardini M, Yaldizli \u00d6, Sethi V, Muhlert N, Wheeler-Kingshott CAM, et al. Magnetization transfer ratio measures in normal-appearing white matter show periventricular gradient abnormalities in multiple sclerosis. Brain. 2015;138:1239\u201346.","journal-title":"Brain"},{"key":"656_CR41","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1177\/1352458519841810","volume":"26","author":"JWL Brown","year":"2020","unstructured":"Brown JWL, Chowdhury A, Kanber B, Prados Carrasco F, Eshaghi A, Sudre CH, et al. Magnetisation transfer ratio abnormalities in primary and secondary progressive multiple sclerosis. Multiple Scler J. 2020;26:679\u201387.","journal-title":"Multiple Scler J"},{"key":"656_CR42","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1093\/brain\/aww296","volume":"140","author":"JWL Brown","year":"2017","unstructured":"Brown JWL, Pardini M, Brownlee WJ, Fernando K, Samson RS, Prados Carrasco F, et al. An abnormal periventricular magnetization transfer ratio gradient occurs early in multiple sclerosis. Brain. 2017;140:387\u201398.","journal-title":"Brain"},{"key":"656_CR43","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1177\/1352458512451941","volume":"19","author":"T Sinnecker","year":"2013","unstructured":"Sinnecker T, Bozin I, D\u00f6rr J, Pfueller CF, Harms L, Niendorf T, et al. Periventricular venous density in multiple sclerosis is inversely associated with T2 lesion count: a 7 Tesla MRI study. Multiple Scler J. 2013;19:316\u201325.","journal-title":"Multiple Scler J"},{"key":"656_CR44","doi-asserted-by":"publisher","first-page":"3165","DOI":"10.1093\/brain\/awl217","volume":"129","author":"P Patrikios","year":"2006","unstructured":"Patrikios P, Stadelmann C, Kutzelnigg A, Rauschka H, Schmidbauer M, Laursen H, et al. Remyelination is extensive in a subset of multiple sclerosis patients. Brain. 2006;129:3165\u201372.","journal-title":"Brain"},{"key":"656_CR45","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1007\/s00401-020-02189-9","volume":"140","author":"K He\u00df","year":"2020","unstructured":"He\u00df K, Starost L, Kieran NW, Thomas C, Vincenten MCJ, Antel J, et al. Lesion stage-dependent causes for impaired remyelination in MS. Acta Neuropathol. 2020;140:359\u201375.","journal-title":"Acta Neuropathol"}],"container-title":["Fluids and Barriers of the CNS"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12987-025-00656-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12987-025-00656-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12987-025-00656-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T02:09:03Z","timestamp":1751422143000},"score":1,"resource":{"primary":{"URL":"https:\/\/fluidsbarrierscns.biomedcentral.com\/articles\/10.1186\/s12987-025-00656-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,8]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["656"],"URL":"https:\/\/doi.org\/10.1186\/s12987-025-00656-7","relation":{},"ISSN":["2045-8118"],"issn-type":[{"value":"2045-8118","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,8]]},"assertion":[{"value":"8 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 July 2025","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This article has been updated to amend the license information","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the local ethics committees of the Ruhr-University Bochum (Approval No. 20\u20137054-BR) and of the LAGeSo Berlin (No. ZS EK 10 407\/08, new: 08\/0407-EK 15 and No. 06\/0510 ZS EK 15). It was conducted according to the Declaration of Helsinki in its applicable version. Every participant provided written informed consent before screening.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"R. Schneider has received consulting and speakers\u2019 honoraria from Roche Pharma AG, Novartis Pharma, Merck KGaA and Alexion Pharma & has received research scientific grant support from Novartis Pharma, all not related to this work; T. Ladopoulos has received a research grant from Novartis Pharma, unrelated to this project; R. Rust has received speaking honoraria from Roche, unrelated to this project; C. Chien received writing honoraria from the British Society for Immunology, is a Standing Committee on Science Member for the CIHR, and has received research support from Novartis and Alexion, and is part of a consortium project funded by the US Department of Defense, unrelated to this project; R. Gold has received research support and speaker\u2019s honoraria from Bayer-Schering, Biogen Idec, BMS, Chugai, Eisai, Genesis, Janssen, Merck Serono, Nikkiso Pharma, Novartis, Roche, Sanofi-Genzyme, Sandoz, and Teva, consulting honoraria from ZLB Behring, Baxter, Roche, and Talecris, and personal stock options in Bayer, Merck, and Roche; F. Paul received support from NeuroCure Clinical Research Center for the present manuscript, has received research support from German Ministry for Education and Research (BMBF), Deutsche Forschungsgemeinschaft (DFG), Einstein Foundation, Guthy Jackson Charitable Foundation, EU FP7 Framework Program, Biogen, Genzyme, Merck Serono, Novartis, Bayer, Roche, consulting fees from Alexion, Roche, Horizon, Neuraxpharm, has received honoraria for lectures, presentations, speakers bureaus from Almirall, Bayer, Biogen, GlaxoSmithKline, Hexal, Merck, Sanofi Genzyme, Novartis, Viela Bio, UCB, Mitsubishi Tanable, Celgene, Guthy Jackson Foundation, Serono, support for attending meetings or travel from Merck, Guthy Jackson Foundation, Bayer, Biogen, Merck Serono, Sanofi Genzyme, Novartis, Alexion, Viela Bio, Roche, UCB, Mitsubishi Tanable, Celgene, participated on a data safety monitoring board or advisory board for Celgene AdBoard, Roche AdBoard, USB AdBoard, Merck AdBoard, is an associatee editor with Neurology, Neuroimmunology, and Neuroinflammation and academic editor with PloS One; C. Lukas received a research grant by the German Federal Ministry for Education and Research, BMBF, German Competence Network Multiple Sclerosis (KKNMS), grant no.01GI1601I, and received consulting and speaker\u2019s honoraria from Biogen Idec, Bayer Schering, BMS, Daiichi Sankyo, Merck Serono, Novartis, Sanofi, Genzyme and TEVA. B. Krieger reports no disclosures relevant to the manuscript. B. Bellenberg reports no disclosures relevant to the manuscript. Z. Abbas reports no disclosures relevant to the manuscript. T. Schmitz-H\u00fcbsch reports no disclosures relevant to the manuscript. A.K. Roenneke reports no disclosures relevant to the manuscript.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial number"}}],"article-number":"47"}}